Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer
Figure 2
Expression of NeuGc-GM3 ganglioside and Ki-67 protein in NMYC-amplified and -nonamplified neuroblastoma. NeuGc-GM3 (open bars) was assessed with the immunoreactive score (IRS) and the percent of Ki-67 positive cells (closed bars) was used as a proliferation index. Data represent mean ± SEM. * ( test)
